ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1970

Detecting Inflammatory Changes in Seronegative Inflammatory Arthritis with Use of Musculoskeletal Ultrasound Studies

Clarice P. Lin1 and Richard C. Chou2, 1University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Department of Medicine, Buffalo, NY, 2University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Division of Allergy, Immunology, & Rheumatology, Department of Medicine, Buffalo, NY

Meeting: ACR Convergence 2022

Keywords: rheumatoid arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster IV

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Recent clinical practice has increasingly utilized musculoskeletal (MS) ultrasound studies to assess inflammation and soft-tissue abnormalities of the joints, such as synovitis and bone erosions. MS ultrasound studies were recently shown to be more sensitive to detect early synovial changes and erosions while maintaining cost-effectiveness compared to other radiographic imaging. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP Ab) have demonstrated key roles in the diagnosis of RA, yet the positive expressivity of these antibodies has been reported as low as 50% in early RA disease. The nature of seronegative RA, which is often subclinical in presentation, has shown further elusiveness in detection, disease course, and treatment response. We hypothesize that MS ultrasound studies are sensitive to and critical in detecting inflammatory changes in seronegative inflammatory arthritis (SNIA) as compared to serological studies in conjunction with physical examination.

Methods: A retrospective analysis of electronic medical records was conducted on patients at two University at Buffalo rheumatology clinics who underwent MS ultrasound studies to rule out inflammatory arthritis. These patients did not meet diagnostic criteria for RA due to a lack of positive serology and/or gross joint swelling, and were previously evaluated by at least one other medical provider who found no evidence of inflammatory arthritis on physical examination or prior family history of psoriatic or other inflammatory arthritis. Data relating to patients’ demographics, MS ultrasound findings, and serological studies was de-identified and tabulated. Measurements of synovial hypertrophy and erosions were categorized by location and presence with immunosuppressive therapy. Further subgroup analysis was performed by analyzing patients with multiple ultrasounds to assess inflammatory disease progression.

Results: Of the 363 patients who underwent MS ultrasound studies, 280 of them (77.1%) of them were found to have synovial hypertrophy [minimal = 21%, mild = 47%, moderate = 30%, severe = 2%] in bilateral MCP, PIP, carpal, wrist, and/or MTP and IP joints, therefore conferring a diagnosis of inflammatory arthritis. The average age of these 280 patients was 48.35 ± 14.86 years old at the time of diagnosis, with female to male ratio of 4.38:1. Surprisingly, of these 280 patients with evidence of inflammatory arthritis, 69 (24.6%) of them were found to have joint erosions with either MCP or MTP joints, supporting a diagnosis of advanced inflammatory arthritis with erosive disease. The erosions were predominantly located in MTP joints (77.1%) as compared to MCP joints (22.9%). Disease progression in these patients was further analyzed using repeat MS ultrasound studies following immunosuppressive therapy.

Conclusion: Our findings clearly demonstrated distinct clinical and ultrasonography features of SNIA. MS ultrasound studies are sensitive to and critical for detecting inflammatory changes and joint damages in SNIA due to its subclinical presentation. Based on our findings, SNIA is likely underdiagnosed in individuals who complain of joint pain without gross synovitis on physical examination.


Disclosures: C. Lin, None; R. Chou, Sun Pharmaceuticals Industries Limited.

To cite this abstract in AMA style:

Lin C, Chou R. Detecting Inflammatory Changes in Seronegative Inflammatory Arthritis with Use of Musculoskeletal Ultrasound Studies [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/detecting-inflammatory-changes-in-seronegative-inflammatory-arthritis-with-use-of-musculoskeletal-ultrasound-studies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detecting-inflammatory-changes-in-seronegative-inflammatory-arthritis-with-use-of-musculoskeletal-ultrasound-studies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology